Written by admin on . Posted in News Feed
- Why there’s excitement and skepticism about new Alzheimer’s drug lecanemab CBC News
- What causes Alzheimer’s disease is still not known, but ‘amyloid cascade hypothesis’ may explain it better Economic Times
- ‘Patients deserve better treatments for dementia’: NHS hopes for new Alzheimer’s drug iNews
- Vivoryon’s lessons on the mixed fortunes for the Alzheimer’s field Labiotech.eu
- View Full Coverage on Google News
Written by admin on . Posted in News Feed
Alzheimer’s blood tests could change research, treatment The Washington Post
Written by admin on . Posted in News Feed
Column: Support funding for Alzheimer’s research, caregiving The Herald-Times
Written by admin on . Posted in News Feed
Are Alzheimer’s researchers thinking about the disease wrong? Slate
Written by admin on . Posted in News Feed
What the Alzheimer’s Drug Breakthrough Means for Other Diseases Bloomberg
Written by admin on . Posted in News Feed
This is the latest research on Alzheimer’s and dementia World Economic Forum
